Approved Study Database

Ref. No. Scientific Title Principal investigator
2025.657 A Phase 1/2 Open-label Study to Investigate the Safety, Efficacy, and Pharmacokinetics of Administration of Subcutaneous Blinatumomab for the Treatment of Adults and Adolescents with Relapsed or Refractory B cell Precursor Acute Lymphoblastic Leukemia (R/R B-ALL) and Minimal Residual Disease Positive (MRD+) B-ALL Prof. LI Chi Kong
李志光教授
2025.621 Novel microbiome signatures for the prediction of dementia-first versus parkinsonism-first conversion in REM sleep behavior disorder Dr. HUANG Bei
2025.661 Unrevealing the multi-level brain reserve against age-related cognitive decline and cardiometabolic risk factors: a three-year follow-up study Dr. LU Hanna
2025.598 Epidemiological Trend and Projections on Disease Burden in Hong Kong Prof. HUANG Junjie
2025.648 A pilot study on the efficacy and safety of a novel synbiotic formula (SGR11) in patients with inflammatory bowel disease (IBD) Prof. Ng Siew Chien
2025.597 Construction of diagnostic and predictive models for cirrhosis patients with complications of liver disease Prof. Wong Grace
2025.604 Clamp catheter versus snare for Inferior Vena Cava filter retrieval: a single centre experience Dr. LAW Wing Chung
2025.588 Exploring the Protective Role of Bacteroides intestinalis against Metabolic Dysfunction-Associated Steatotic Liver Disease Prof. ZHANG Xiang
2025.605 A Phase I/II, Open-label, Multicenter Study of ALE.P03 (Claudin-1 Targeted Antibody-drug Conjugate) as a Monotherapy in Adult Patients with Selected Advanced or Metastatic CLDN1+ Solid Tumors Prof. CHAN Stephen Lam
2025.616 The Effects of Transcranial Temporal Interference Stimulation to the Amygdala on Emotion Regulation and Conflict Resolution Dr. LIU Xiaonan
2025.628 A Phase 1 Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Clinical Activity of GSK5764227 as Monotherapy and in Combination in Participants with Advanced Solid Tumors Dr. LOONG Herbert Ho Fung
2025.589 A Phase 3, Randomized, Open-label, Study to Compare the Efficacy and Safety of Adjuvant MK-2870 in Combination with Pembrolizumab (MK-3475) Versus Treatment of Physician’s Choice (TPC) in Participants With Triple-Negative Breast Cancer (TNBC) Who Received Neoadjuvant Therapy and Did Not Achieve a Pathological Complete Response (pCR) at Surgery Prof. YEO Winnie
2025.777 Speech Disfluency Analysis to Predict Cognitive Impairment --- Developing a Speech Disfluency Framework Prof. Law Thomas
2025.590 A Phase III, Open-label, Randomised Study of Datopotamab Deruxtecan (Dato-DXd) With or Without Durvalumab Compared with Investigator’s Choice of Chemotherapy (Paclitaxel, Nab-paclitaxel or Gemcitabine + Carboplatin) in Combination With Pembrolizumab in Patients with PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer (TROPION-Breast05) Prof. YEO Winnie
2025.596 Deciphering the role of ADAT2-mediated transfer RNA A-to-I modification in colorectal tumorigenesis and chemoresistance Dr. WONG Chi Chun
Chi Chun Wong
2025.668 Knowledge on heart attack and stroke symptoms recognition in Hong Kong residents: a cross-sectional survey Mr. WONG Yin Fung
黃然豐
2025.619 Review of Clinical Outcomes of Structured Non-Surgical Treatment Programme for Knee Osteoarthritis in Prince of Wales Hospital Ms. Li Man Kuen
2025.631 AI Screening of Head CT scans for Cognitive Decline Dr. Abrigo Jill
2025.582 Territorial big data analysis of clinicopathological parameters and clinical diagnosis, outcomes and epidemiological trends in human neoplasms Dr. LAI Hei Ming
2025.584 Local epidemiology, prevalence and clinical outcomes of subjects with preserved ratio impaired spirometry Dr. KO Fanny Wai San
2025.583 Clinical features and Treatment outcomes in Paediatric probable antibody-negative autoimmune encephalitis in Hong Kong Dr. YAM Karen Kwan Ming
2025.553 Life-Style Medicine for Chronic Musculoskeletal Pain in Older People: A pragmatic, randomized controlled clinical trial Prof. Sit Regina Wing Shan
2025.549 Biomarkers for prediction, monitoring and follow-up of pregnancy complications Prof. POON Liona Chiu Yee
2025.567 Large language models for cancer staging based on head and neck radiology reports Dr. WONG Matthew Lun
2025.576 Hong Kong Traditional Chinese Medicine and Western Medicine IVF-ET Treatment Model: Construction and Optimization of Medical Communication Dr. LAM Lai Kwan
2025.552 The Effectiveness of A Multicomponent Sleep Intervention in Individuals Living in Residential Services – A Cluster Randomised Controlled Trial Dr. CHAN Ngan Yin
Ngan Yin
2025.551 Evaluation of the effectiveness of a one-day multi-component hospital attachment program on the well-being of secondary school students in Hong Kong Dr. CHAN Kai Tai
2025.550 The Evaluation of Safety, Tolerability, and Pharmacokinetics of ProEGCG Prof. Wang Ronald Chi Chiu
2025.566 Cardioneural temporary pacing to achieve autonomic modulation Dr. TAM Tsz Kin
譚子健
2025.568 Use of Artificial Intelligence in Building an Innovative Intestinal Ultrasound Learning Model Dr. MAK Joyce Wing Yan
2025.547 Predictive models of dyslexia diagnosis and intervention success in early-grade primary school children: validation across cross-sectional, retrospective, and prospective longitudinal samples using EEG and behavioral data Dr. Maurer Urs
2025.586 A Phase 1/2a, Open-Label, Multiple-Cohort, Dose-Escalation Study to Evaluate the Safety, Tolerability, and Preliminary Efficacy of Intravitreal (IVT) Injection of ABI-110 (AAV2.N54-VEGF Trap) in Subjects with Neovascular (Wet) Age-Related Macular Degeneration (wAMD), Including Symptomatic Macular Polypoidal Choroidal Vasculopathy (PCV) Dr. BRELEN Marten
2025.569 Effects of SGLT2 inhibitors on benign prostatic hyperplasia progression in type 2 diabetes: a target trial emulation Dr. LUI Juliana Nga Man
2025.548 Investigating the Non-Motor Effects on Olfaction of Deep Brain Stimulation in Patients with Parkinson’s Disease (PD) Dr. CHAN Danny Tat Ming
2025.653 Individualised Management of Sepsis based on the construction of novel subtyping system Dr. LING Lowell
2025.630 Left Atrial Appendage Occlusion in Dialysis Patients with Atrial Fibrillation: A Multicentre Pilot Study Dr. SO Kent Chak Yu
2025.545 Per-oral endoscopic myotomy (POEM) for achalasia – A Prospective study on Long-term outcomes Dr. YIP Hon Chi
葉瀚智
2025.565 Prognostic significance of FOXA1, FOXA2 and IL-11 in prostate cancer Dr. YAN Kelvin
2025.538 Randomised, double-blind and placebo-controlled clinical trial on microbiome-based preventive strategies for early-onset eczema in Chinese infants Prof. LEUNG Ting Fan
梁廷勳
2025.564 Complex interplay between hepatic steatosis and chronic hepatitis B on liver-related clinical outcomes Dr. YIP Cheuk Fung
葉卓風
2025.544 A Randomised, Double-blind, Placebo-controlled, Multi-centre, Sequential Phase II, and Phase III Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of AZD0780 Administered for up to 52 Weeks in Participants with Dyslipidaemia (AZURE-CHINA) Prof. MA Ching Wan
馬青雲
2025.570 Imaging and endovascular treatment for post-irradiation pseudoaneurysms after skull base irradiation for nasopharyngeal carcinoma Dr. YIU Ka Sang
2025.543 Building Resilience Against Rising Temperature - The Effect of High-Intensity Interval Exercise (HIIE) on Heat Tolerance, Thermoregulatory Adaptation, and Physical Fitness: A Comparative Randomized Controlled Trial Prof. POON Eric Tsz Chun
潘梓竣
2025.523 Predicting Self-Harm in Hong Kong: An AI-Driven Framework Integrating Clinical, Socioeconomic, and Environmental Data for Individual Risk Stratification Dr. VERMA Rohit Kumar
2025.522 Validation of Diagnostic Coding for Pneumonia in Patients with Presumed Infection in the Electronic Health Record System of Hong Kong Dr. VERMA Rohit Kumar
2025.521 Identifying the Risk Factors of Suicide Related Visits at the Emergency Department in Hong Kong Dr. VERMA Rohit Kumar
2025.537 Effects of a sitting Tai Chi programme for chronic stroke survivors with post-stroke cognitive impairment: A pilot randomised controlled trial Dr. ZHAO Jie
2025.536 Adopting Integrated Care for Older People (ICOPE) Framework for Assessing Intrinsic Capacity in People Aging with HIV Dr. LUI Grace C.Y.
2025.563 A Prospective Registry for Belzutifan in the Treatment of von Hippel-Lindau (VHL) Disease Prof. NG Chi Fai
2025.542 Air purifier and respiratory outcomes in childhood asthma in compromised housing environments: a hybrid effectiveness-implementation trial Dr. CHAN Crystal Ying

Page 7 of 277.